Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It has a partnership agreement with Merck & Co. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents. The company is headquartered in Marina del Rey, California.
What is Armata Pharmaceuticals stock price today?▼
The current price of ARMP.BOATS is $8.13 USD — it has decreased by -4.69% in the past 24 hours. Watch Armata Pharmaceuticals stock price performance more closely on the chart.
What is Armata Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Armata Pharmaceuticals stocks are traded under the ticker ARMP.BOATS.
What is Armata Pharmaceuticals market cap?▼
Today Armata Pharmaceuticals has the market capitalization of 295.36M
When is the next Armata Pharmaceuticals earnings date?▼
Armata Pharmaceuticals is going to release the next earnings report on May 07, 2026.
What were Armata Pharmaceuticals earnings last quarter?▼
ARMP.BOATS earnings for the last quarter are -0.74 USD per share, whereas the estimation was -0.42 USD resulting in a -76.19% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Armata Pharmaceuticals revenue for the last year?▼
Armata Pharmaceuticals revenue for the last year amounts to 10.35M USD.
What is Armata Pharmaceuticals net income for the last year?▼
ARMP.BOATS net income for the last year is -37.83M USD.
When did Armata Pharmaceuticals complete a stock split?▼
Armata Pharmaceuticals has not had any recent stock splits.